Elsevier Tweaks Custom Pub Rules

June 5, 2009
Publishing company Elsevier is revising its policies and procedures for partnering with pharmaceutical companies to create custom publications in response to recent media attention over a fake journal, called the Australasian Journal of Bone and Joint Medicine, created by the company and paid for by Merck.
The Scientist